in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Johnson Matthey to Close Prostaglandin API Facility in Ireland
11:18 AM MDT | April 10, 2009 | DEEPTI RAMESH
Johnson Matthey says it plans to close its prostaglandin active pharmaceutical ingredient (API) facility at Cork, Ireland with the loss of 21 jobs, due to poor demand in the European market. The company says it plans to consolidate manufacturing of prostaglandin products at its U.S. facility at Devens, MA. Johnson Matthey inherited the facility when it acquired Cascade Biochem (Cork), a manufacturer and supplier of prostaglandins and other complex molecules as APIs, in 2002. “Johnson Matthey acquired Cascade Biochem and its prostaglandin API site with a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: